Coeptis Therapeutics Inc (COEP) — Financial Flexibility Index
Coeptis Therapeutics Inc (COEP) has a Financial Flexibility Index of -0.66x as of September 2025. Free cash flow of $-2.15 Million (operating CF $-2.15 Million minus capex $3.00) represents -1% of total liabilities ($3.26 Million). Check COEP strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Coeptis Therapeutics Inc Financial Flexibility Index (2004–2024)
Historical Financial Flexibility Index trend for Coeptis Therapeutics Inc across 9 annual periods. See Coeptis Therapeutics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Coeptis Therapeutics Inc (2004–2024)
Year-by-year free cash flow to debt coverage for Coeptis Therapeutics Inc. For the full company profile including market capitalisation, see Coeptis Therapeutics Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.32x | $-6.65 Million | $-6.65 Million | $5.04 Million | ▼ -17.8% |
| 2023 | -1.12x | $-3.88 Million | $-3.88 Million | $3.46 Million | ▲ +10.1% |
| 2022 | -1.25x | $-3.88 Million | $-3.88 Million | $3.11 Million | ▼ -100.7% |
| 2021 | -0.62x | $-2.74 Million | $-4.49 Million | $4.41 Million | ▼ -7.7% |
| 2020 | -0.58x | $-3.14 Million | $-3.14 Million | $5.44 Million | ▲ +0.3% |
| 2019 | -0.58x | $-90.03K | $-90.07K | $155.85K | ▲ +95.7% |
| 2018 | -13.47x | $-836.27K | $-839.06K | $62.07K | ▼ -2178.3% |
| 2005 | -0.59x | $-417.02K | $-417.02K | $705.22K | ▼ -111.8% |
| 2004 | 5.00x | $1.55 Million | $1.55 Million | $310.94K | — |